Cancer Therapy News and Research

RSS

Alternative method to produce heparin

Researchers at Rensselaer Polytechnic Institute and University of North Carolina at Chapel Hill have discovered an alternative way to produce heparin, a drug commonly used to stop or prevent blood from clotting.

7 Feb 2006

Vaccine against ricin safe and effective

Scientists at the University of Texas Southwestern Medical Center at Dallas, say a vaccine against the deadly toxin ricin is safe and effective.

31 Jan 2006

Study may provide new hope for cancer patients

New study by Mount Sinai researchers may lead to improved stem cell therapies for patients with compromised immune systems due to intensive cancer therapy or autoimmune disease. The study is published in this week's issue of Cell.

27 Jan 2006

Breast ducts - A new site for cancer treatment!

Johns Hopkins Kimmel Cancer Center researchers are studying whether delivering chemotherapy drugs directly to breast "plumbing" might make treatment of early breast cancer easier on the patient and at least as good as surgery or radiation.

26 Jan 2006

Tumor cell growth depends on interactions with its microenvironment

An EU funded Specific Targeted Research Project (STREP) entitled "Tumor-Host Genomics" has been launched at the University of Helsinki, Finland.

26 Jan 2006

No link between reduced cancer risk and Omega-3 fatty acids

Researchers in the U.S. have found in a comprehensive review of numerous studies, that there is little evidence to support the belief that the consumption of omega-3 fatty acids reduces risk of cancer.

26 Jan 2006

Omega-3 fatty acids appear not to reduce cancer risk

A review of numerous studies finds no strong evidence indicating a significantly reduced risk of cancer associated with the consumption of omega-3 fatty acids, according to an article in the January 25 issue of JAMA: The Journal of the American Medical Association.

25 Jan 2006

Guidelines for International Breast Health and Cancer Control

Specific recommendations for improving breast-health care and cancer treatment in countries with limited resources have been published by the Breast Health Global Initiative (BHGI), an international coalition of doctors, scientists, policy makers and advocates led by Fred Hutchinson Cancer Research Center and the Susan G. Komen Breast Cancer Foundation.

25 Jan 2006

Bexarotene shows promise in cancer treatment.

Researchers at Washington University School of Medicine in St. Louis now report that a compound related to vitamin A shows promise in preventing or slowing tumor growth in mice prone to lung cancer. The compound, called bexarotene, doesn't cause the severe skin irritations that have limited the use of other vitamin A derivatives in cancer therapies.

18 Jan 2006

rhTSH combined with radiation therapy successfully destroys remaining thyroid tissue

A multicenter international study, including Johns Hopkins, has found that after surgery for thyroid cancer, giving genetically engineered human thyroid-stimulating hormone (rhTSH) before radioiodine treatment avoids the previous need to stop thyroid replacement therapy and the miserable side effects that go with it.

9 Jan 2006

Caspase 8 gene halts spread of aggressive childhood cancer

A team of cancer researchers has shown that a gene commonly lost during neuroblastoma tumor formation, one of the most aggressive cancers in babies and children, is in fact a "metastasis suppressor" gene.

6 Jan 2006

A good year for breast cancer detection and treatment

It was a good year in women’s health, notably breast cancer treatment and detection. The December issue of Mayo Clinic Women’s HealthSource hails these important advances of 2005.

29 Dec 2005

Blacks more likely to die of curable lung cancer than whites

Even when they have equal access to specialized care, blacks with potentially curable lung cancer are about half as likely as whites to undergo surgery that could save their lives, according to a study by Dana-Farber Cancer Institute researchers.

28 Dec 2005

New strategies required to get blacks and Asians to participate in cancer trials

The better informed people are about cancer clinical trials, the more likely they are overall to consider participating in a trial, according to a UC Davis study published in today's issue of the Journal of Clinical Oncology. However, knowing about cancer clinical trials does not appear to increase participation among black and Asian Americans.

21 Dec 2005